GSRF
NASDAQ · N/A
Gsr Iv Acquisition Corp-Cl A
$10.19
+0.01 (+0.11%)
Open$10.19
Previous Close$10.18
Day High$10.19
Day Low$10.19
52W High$10.20
52W Low$9.96
Volume—
Avg Volume32.5K
Market Cap299.35M
P/E Ratio74.54
EPS$0.14
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 146.09M | 153.79M | 147.45M |
| Net Income | 10.19M | 14.28M | 11.11M |
| Profit Margin | 7.0% | 9.3% | 7.5% |
| EBITDA | 17.65M | 19.50M | 17.14M |
| Free Cash Flow | 14.65M | 14.16M | 16.41M |
| Rev Growth | +20.6% | +16.4% | -5.4% |
| Debt/Equity | 0.07 | 0.10 | 0.08 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $3.02 | +8.24% | — | 1.41B |
| PICS | Pics Nv | $10.27 | +0.49% | 6.6 | 1.48B |
| DMII | Drugs Made In America Acquis | $10.12 | -0.10% | 75.2 | 645.28M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.73 | -0.05% | 35.5 | 336.67M |
| CEPF | Cantor Equity Partners-Cl A | $10.40 | +0.48% | 57.9 | 595.50M |